Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
May 22, 2020

Sunovion gets FDA nod for Kynmobi to treat Parkinson’s disease off episodes

Sunovion Pharmaceuticals has secured approval from the US Food and Drug Administration (FDA) for its Kynmobi (apomorphine hydrochloride) sublingual film (APL-130277) to treat Parkinson’s disease (PD) off episodes.

Continue
Sunovion has secured FDA approval for Kynmobi to treat Parkinson’s disease off episodes. (Credit: Sunovion Pharmaceuticals Inc.)
May 22, 2020

Appili set to evaluate favipiravir as preventive measure against Covid-19

Appili Therapeutics gets Health Canada’s approval for trialing favipiravir as preventive measure against Covid-19. (Credit: Pete Linforth from Pixabay)
May 19, 2020

Moderna’s Covid-19 vaccine shows significant effect in early human trial

Moderna’s Covid-19 vaccine has demonstrated significant effect in early human trial. (Credit: PIRO4D from Pixabay)

Contracts

May 15, 2020

Takeda gets expanded EC approval for lymphoma drug Adcetris

The head office of Takeda Pharmaceutical Company, in Chuo-ku, Osaka, Japan. (Courtesy of J o / Wikimedia Commons)

Concert Pharmaceuticals announces plans for CTP-543 phase 3 trials in alopecia areata

ViiV Healthcare, NIH collaborate on investigational bNAb for HIV treatment

WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract

Deals

Deals May 6, 2020

Alexion to buy biopharmaceutical firm Portola in $1.41bn deal

Pharmaceutical Business Review

Affinia secures $1.6bn worth deal from Vertex to develop AAV capsids for genetic therapies

AbbVie receives marketing authorisation from EC to shorten MAVIRET duration for treatment-naïve genotype 3 HCV patients with compensated cirrhosis

Gilead Sciences to buy immuno-oncology firm Forty Seven for $4.9bn

Popular

  1. Gilead, Renown Institute for Health Innovation announce collaboration to advance understanding of NASH
  2. Celsius Therapeutics signs collaboration agreement with Janssen to identify response biomarkers for ulcerative colitis
  3. Ipsen, Servier announce initial phase 1/2 data of liposomal irinotecan in metastatic pancreatic cancer
  4. VALBIOTIS announces positive results from phase IIA trial of VALEDIA in prediabetics
  5. GSK begins phase 3 trial for otilimab in patients with rheumatoid arthritis

PRESS RELEASES

NSF Now Offering Live Instructor-Led Virtual Pharmaceutical and Medical Devices Training
NSF Now Offering Live Instructor-Led Virtual Pharmaceutical and Medical Devices Training
Softigel by Procaps statement on COVID-19
Softigel by Procaps statement on COVID-19
Outsourcing in Clinical Trials – A Virtual Experience
Outsourcing in Clinical Trials – A Virtual Experience
Enamine and Chemspace Collaborate with Blue Dolphin Lead Discovery to Expand Drug Discovery Services
Enamine and Chemspace Collaborate with Blue Dolphin Lead Discovery to Expand Drug Discovery Services
Vetter’s High Performance is Again Recognised at the 2020 CMO Leadership Awards
Vetter’s High Performance is Again Recognised at the 2020 CMO Leadership Awards

Suppliers

Whitepapers

Fluorosulfates and Sulfamoyl Fluorides for Drug Design
Fluorosulfates and Sulfamoyl Fluorides for Drug Design
InPro 7100 Series
InPro 7100 Series
Alkyne-containing Linkers
Alkyne-containing Linkers